RAC 2.20% $1.78 race oncology ltd

When the big end of town who invest in biotechnology companies...

  1. 1,233 Posts.
    lightbulb Created with Sketch. 12283
    When the big end of town who invest in biotechnology companies recognize the peak revenue opportunities for a first-in-class CPACS, do you or anyone else think they will sit idle on the sidelines and miss out?

    Seems like it might even be part of RACs plan - to tip off one of the big-time biotech investment firms when...oh, I don't know, maybe when CPACS is validated in P1a/b.

    RAC will probably also be at international conferences talking about the world-first by then too. Investment organizations that frequent those conferences probably want to miss out too.

    These people love making money. In biotech, you make the most money from first-in-class platform plays.
    Last edited by Mason14: 19/08/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.